87 related articles for article (PubMed ID: 6298832)
41. Effect of alpha-melanocyte-stimulating hormone on basal and stimulated release of prolactin: evidence for dopaminergic mediation.
Khorram O; Mizunuma H; McCann SM
Neuroendocrinology; 1982 Jun; 34(6):433-7. PubMed ID: 7099389
[TBL] [Abstract][Full Text] [Related]
42. 99mTc-sodium pertechnetate permeation into cerebrospinal fluid.
Borkar A; DaCosta H
Clin Nucl Med; 1979 Jul; 4(7):294-5. PubMed ID: 466905
[TBL] [Abstract][Full Text] [Related]
43. The effect of alpha-melanocyte stimulating hormone (alpha-msh) on the metabolism of biogenic amines in the rat brain.
Leonard BE; Kafoe WF; Thody AJ; Shuster S
J Neurosci Res; 1976; 2(1):39-45. PubMed ID: 933208
[TBL] [Abstract][Full Text] [Related]
44. Mahogany (1377-1428) enters brain by a saturable transport system.
Kastin AJ; Akerstrom V
J Pharmacol Exp Ther; 2000 Aug; 294(2):633-6. PubMed ID: 10900242
[TBL] [Abstract][Full Text] [Related]
45. Natriuretic properties of melanocyte-stimulating hormones.
Valentin JP; Wiedemann E; Humphreys MH
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S114-8. PubMed ID: 7508015
[TBL] [Abstract][Full Text] [Related]
46. Alpha-melanocyte stimulating hormone discloses a stimulatory effect of beta-endorphin on somatostatin release.
Aguila MC; Khorram O; McCann SM
Brain Res; 1987 Aug; 417(1):127-30. PubMed ID: 2887255
[TBL] [Abstract][Full Text] [Related]
47. The hemodynamic effects of gamma 2-melanocyte-stimulating hormone and related melanotropins depend on the arousal potential of the rat.
De Wildt DJ; Krugers H; Kasbergen CM; De Lang H; Versteeg DH
Eur J Pharmacol; 1993 Mar; 233(1):157-64. PubMed ID: 8386086
[TBL] [Abstract][Full Text] [Related]
48. Alpha-melanocyte stimulating hormone (MSH) antagonizes the anorexia by corticotropin releasing factor (CRF).
Oohara M; Negishi M; Shimizu H; Sato N; Mori M
Life Sci; 1993; 53(19):1473-7. PubMed ID: 8412510
[TBL] [Abstract][Full Text] [Related]
49. Selective blood-tumor barrier disruption by leukotrienes.
Chio CC; Baba T; Black KL
J Neurosurg; 1992 Sep; 77(3):407-10. PubMed ID: 1506887
[TBL] [Abstract][Full Text] [Related]
50. Cardiovascular responses to alpha-melanocyte stimulating hormone during the perinatal period in sheep.
Llanos AJ; Seron-Ferre M; Ramachandran J; Creasy RK; Heymann MA; Rudolph AM
Pediatr Res; 1983 Nov; 17(11):903-8. PubMed ID: 6316245
[TBL] [Abstract][Full Text] [Related]
51. Effect of prolyl-leucyl-glycinamide and alpha-melanocyte-stimulating hormone on levorphanol-induced analgesia, tolerance and dependence.
Contreras PC; Takemori AE
Life Sci; 1984 Jun; 34(26):2559-66. PubMed ID: 6146083
[TBL] [Abstract][Full Text] [Related]
52. Structural modifications of pro-opiomelanocortin-derived peptides alter their behavioral effects markedly.
Hirsch MD; O'Donohue TL
J Pharmacol Exp Ther; 1986 May; 237(2):378-85. PubMed ID: 2939234
[TBL] [Abstract][Full Text] [Related]
53. [Experimental study of the mechanism of local radiation damage to the brain by means of penetration of 99mTc through the hematoencephalic barrier].
Zolotov VA; Lomanov MF; Luk'iashin VE; Shimchuk GG; Minakova EI
Med Radiol (Mosk); 1982 Jul; (7):53-8. PubMed ID: 6289036
[No Abstract] [Full Text] [Related]
54. [Use of a technetium radionuclide complex to study blood-brain barrier permeability].
Dvorskiĭ OV; Chibisov VA
Voen Med Zh; 1982 Apr; (4):59-60. PubMed ID: 6283732
[No Abstract] [Full Text] [Related]
55. Effects of hepatic ischemia-reperfusion injury on the blood-brain barrier permeability to [
Miah MK; Bickel U; Mehvar R
Metab Brain Dis; 2017 Dec; 32(6):1903-1912. PubMed ID: 28779418
[TBL] [Abstract][Full Text] [Related]
56. Comparison of the radiotoxicity of the
Maucksch U; Runge R; Wunderlich G; Freudenberg R; Naumann A; Kotzerke J
Int J Radiat Biol; 2016 Nov; 92(11):698-706. PubMed ID: 27117205
[TBL] [Abstract][Full Text] [Related]
57. The effects of cortisol, vasopressin (AVP), and corticotropin-releasing factor administration on pulsatile adrenocorticotropin, alpha-melanocyte-stimulating hormone, and AVP secretion in the pituitary venous effluent of the horse.
Livesey JH; Donald RA; Irvine CH; Redekopp C; Alexander SL
Endocrinology; 1988 Aug; 123(2):713-20. PubMed ID: 2840266
[TBL] [Abstract][Full Text] [Related]
58. MSH and MIF-I in animal models of tardive dyskinesia.
Davis KL; Kastin AJ; Beilstein BA; Vento AL
Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
[TBL] [Abstract][Full Text] [Related]
59. Central vasopressin system mediation of acute pressor effect of gamma-MSH.
Gruber KA; Eskridge SL
Am J Physiol; 1986 Jul; 251(1 Pt 1):E134-7. PubMed ID: 3014888
[TBL] [Abstract][Full Text] [Related]
60. Prevention of reflex natriuresis after acute unilateral nephrectomy by melanocortin receptor antagonists.
Ni XP; Kesterson RA; Sharma SD; Hruby VJ; Cone RD; Wiedemann E; Humphreys MH
Am J Physiol; 1998 Apr; 274(4):R931-8. PubMed ID: 9575953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
